Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P M Graham-Brown

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Heart (British Cardiac Society)|September 26, 2019
Emerging glucose-lowering therapies: a guide for cardiologistsGaurav S Gulsin, Matthew P M Graham-Brown, Melanie J Davies, et al.
Journal of Nephrology|July 12, 2025
Supporting people with chronic kidney disease to self-manage their condition: understanding the lived experiences, needs and requirements, and barriers and facilitatorsCourtney J Lightfoot, Thomas J Wilkinson, Matthew P M Graham-Brown, et al.
Clinical Kidney Journal|November 28, 2015
A 4-month programme of in-centre nocturnal haemodialysis was associated with improvements in patient outcomesMatthew P M Graham-Brown, Darren R Churchward, Alice C Smith, et al.
Nephrology (Carlton, Vic.)|June 6, 2014
Physiological benefits of exercise in pre-dialysis chronic kidney diseaseDouglas W Gould, Matthew P M Graham-Brown, Emma L Watson, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 6, 2017
The Potential Cardiovascular Benefits of Low-Glucose Degradation Product, Biocompatible Peritoneal Dialysis Fluids: A Review of the LiteratureCharlotte E Grantham, Katherine L Hull, Matthew P M Graham-Brown, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 7, 2020
The effect of extended-hours hemodialysis on outcomes: A systematic review and meta-analysisKatherine L Hull, Daniel S March, Darren R Churchward, et al.
Heart (British Cardiac Society)|May 11, 2021
Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseasesGaurav S Gulsin, Matthew P M Graham-Brown, Iain B Squire, et al.
European Journal of Radiology|May 7, 2021
Differences in native T1 and native T2 mapping between patients on hemodialysis and control subjectsMatthew P M Graham-Brown, Gaurav S Gulsin, Federica Poli, et al.
BMJ Open|September 10, 2016
Investigating the effects of 6 months extended duration, in-centre nocturnal versus conventional haemodialysis treatment: a non-randomised, controlled feasibility studyDarren R Churchward, Matthew P M Graham-Brown, Robert Preston, et al.
Clinical Kidney Journal|August 31, 2017
The importance of accurate measurement of aortic stiffness in patients with chronic kidney disease and end-stage renal diseaseSherna F Adenwalla, Matthew P M Graham-Brown, Francesca M T Leone, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Heart (British Cardiac Society)|September 26, 2019
Emerging glucose-lowering therapies: a guide for cardiologistsGaurav S Gulsin, Matthew P M Graham-Brown, Melanie J Davies, et al.
Journal of Nephrology|July 12, 2025
Supporting people with chronic kidney disease to self-manage their condition: understanding the lived experiences, needs and requirements, and barriers and facilitatorsCourtney J Lightfoot, Thomas J Wilkinson, Matthew P M Graham-Brown, et al.
Clinical Kidney Journal|November 28, 2015
A 4-month programme of in-centre nocturnal haemodialysis was associated with improvements in patient outcomesMatthew P M Graham-Brown, Darren R Churchward, Alice C Smith, et al.
Nephrology (Carlton, Vic.)|June 6, 2014
Physiological benefits of exercise in pre-dialysis chronic kidney diseaseDouglas W Gould, Matthew P M Graham-Brown, Emma L Watson, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 6, 2017
The Potential Cardiovascular Benefits of Low-Glucose Degradation Product, Biocompatible Peritoneal Dialysis Fluids: A Review of the LiteratureCharlotte E Grantham, Katherine L Hull, Matthew P M Graham-Brown, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 7, 2020
The effect of extended-hours hemodialysis on outcomes: A systematic review and meta-analysisKatherine L Hull, Daniel S March, Darren R Churchward, et al.
Heart (British Cardiac Society)|May 11, 2021
Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseasesGaurav S Gulsin, Matthew P M Graham-Brown, Iain B Squire, et al.
European Journal of Radiology|May 7, 2021
Differences in native T1 and native T2 mapping between patients on hemodialysis and control subjectsMatthew P M Graham-Brown, Gaurav S Gulsin, Federica Poli, et al.
BMJ Open|September 10, 2016
Investigating the effects of 6 months extended duration, in-centre nocturnal versus conventional haemodialysis treatment: a non-randomised, controlled feasibility studyDarren R Churchward, Matthew P M Graham-Brown, Robert Preston, et al.
Clinical Kidney Journal|August 31, 2017
The importance of accurate measurement of aortic stiffness in patients with chronic kidney disease and end-stage renal diseaseSherna F Adenwalla, Matthew P M Graham-Brown, Francesca M T Leone, et al.
Pageof 8